ライフサイエンスコーパス: multivitamin

1 may be too well-nourished to benefit from a multivitamin.

2 entrations were lower in subjects who used a multivitamin.

3 .15 [0.93 to 1.43]) compared to the low-dose multivitamin.

4 er by supplementation with folic acid plus a multivitamin.

5 le evidence supporting the prescription of a multivitamin.

6 y vitamin D (2000 IU), calcium (600 mg), and multivitamins.

7 (95% CI, 0.77 to 1.15) for patients who used multivitamins.

8 telomere length among women who did not take multivitamins.

9 actors, such as physical activity and use of multivitamins.

10 roidal anti-inflammatory drugs, statins, and multivitamins.

11 upplements and 26% to 77% reported using any multivitamins.

12 Ninety-one percent of participants consumed multivitamins.

13 ts not taking Centrum (Pfizer, New York, NY) multivitamins.

14 into 1) no current use and 2) current use of multivitamins.

15 progression than did those who received the multivitamin alone (P = 0.04).

16 Multivitamins alone and selenium supplementation alone w

17 and multivitamins (vitamins A, C, and D) or multivitamins alone for 3 months.

18 .0 [9.0] years in those receiving the active multivitamin and 64.0 [9.1] years in those receiving the

19 intake over the past year and 10-year use of multivitamin and individual vitamin D supplements on a b

20 assigned to an oral, 28-component, high-dose multivitamin and multimineral mixture or placebo.

21 itive performance did not differ between the multivitamin and placebo groups on the secondary outcome

22 mean cognitive change over time between the multivitamin and placebo groups or in the mean level of

23 5% CI, 0.88-1.09; P=.76), colorectal cancer (multivitamin and placebo groups, 1.2 and 1.4 events, res

24 reduction in the incidence of total cancer (multivitamin and placebo groups, 17.0 and 18.3 events, r

25 difference in the risk of cancer mortality (multivitamin and placebo groups, 4.9 and 5.6 events, res

26 of a daily multivitamin on prostate cancer (multivitamin and placebo groups, 9.1 and 9.2 events, res

27 Multivitamin and vitamin E use were not associated with

28 All participants received a multivitamin and were randomly assigned to oral DHA (30

29 ncy, dose) during the previous 10 years from multivitamins and individual supplements/mixtures.

30 Multivitamins and multiminerals are widely used in the U

31 High-dose oral multivitamins and multiminerals did not statistically si

32 entation with a single supplement containing multivitamins and selenium was safe and significantly re

33 Multivitamins and the enhanced mebendazole regimen had a

34 In cause-specific analyses, use of multivitamins and use of vitamin E were associated with

35 Other variables included energy, nutrients, multivitamins, and alcohol.

36 one therapy, alcohol use, physical activity, multivitamins, and calcium supplements, and negatively a

37 supplements, such as vitamin B6, vitamin A, multivitamins, antioxidants, and iron and dietary interv

38 While high doses of multivitamins, antioxidants, or lutein and zeaxanthin ar

39 Whether high-dose multivitamins are effective for secondary prevention of

40 Multivitamins are the most commonly used supplement in t

41 Although multivitamins are used to prevent vitamin and mineral de

42 Although multivitamins are widely used, there are limited prospec

43 who recurred or died within 90 days of their multivitamin assessment.

44 Multivitamins at multiple and single doses of the RDA ha

45 ted state, with dairy products, antacids, or multivitamins avoided for >=4 hours after dosing.

46 study was to evaluate the effect of VA/BC or multivitamin (B complex, vitamin C, and vitamin E) suppl

47 l trial of supplementation with either daily multivitamins (B vitamins and vitamins C and E), seleniu

48 , placebo-controlled trial of a common daily multivitamin, began in 1997 with continued treatment and

49 or ascorbic acid determination in samples of multivitamin beverages, milk, fermented milk, and milk c

50 Na, P and Zn) determination in multimineral/multivitamins by atomic emission spectrometry in a mediu

51 o-controlled trial testing multivitamin use (multivitamin [Centrum Silver] or placebo daily) among US

52 results for the effects of periconceptional multivitamins containing folic acid and of folic acid fo

53 65 years or older, long-term use of a daily multivitamin did not provide cognitive benefits.

54 lation of US male physicians, taking a daily multivitamin did not reduce major cardiovascular events,

55 For participants taking multivitamins during the study, the highest intake of di

56 idering the use of supplements, other than a multivitamin, during chemotherapy.

57 or age, smoking, physical activity, alcohol, multivitamins, family history, diet quality, energy inta

58 After adjustment for confounders, including multivitamins, family history, high triglycerides at bas

59 entions: chlorine for water purification and multivitamins for micronutrient deficiencies.

60 assess the balance of benefits and harms of multivitamins for the prevention of cardiovascular disea

61 National brand name and generic multivitamin formulations for age-related macular degene

62 Multivitamin formulations with or without minerals are t

63 disease prevention is stronger than that for multivitamins, formulations that cry out for greater sta

64 supplements of either single or multiple RDA multivitamins from enrollment until 6 wk after delivery.

65 There were 138 child deaths in the multivitamin group and 124 deaths in the placebo group (

66 significant AMD, there were 152 cases in the multivitamin group and 129 cases in the placebo group (H

67 The rates of prematurity were 16.9% in the multivitamin group and 16.7% in the placebo group (relat

68 rth weight was 7.8% among the infants in the multivitamin group and 9.4% among those in the placebo g

69 There were 872 cataracts in the multivitamin group and 945 cataracts in the placebo grou

70 tational age (<10th percentile; 10.7% in the multivitamin group vs. 13.6% in the placebo group; relat

71 (P = 0.007) were significantly lower in the multivitamin group.

72 tiple RDA (3045 + or - 549 g) and single RDA multivitamins group (3052 + or - 534 g; P = 0.83).

73 Compared with placebo, men taking a daily multivitamin had a statistically significant reduction i

74 Further, a daily multivitamin had no effect on total MI (3.9 and 4.2 even

75 The multivitamin had no effects.

76 o, the children born to mothers who received multivitamins had a reduced risk of anemia.

77 ent with a high-dose folic acid, B6, and B12 multivitamin in kidney transplant recipients did not red

78 ge who consumed a folic acid (FA)-containing multivitamin in the era of FA fortification are lacking.

79 e first 2 y postpartum: multivitamin, VA/BC, multivitamin including VA/BC, or placebo.

80 odeficiency virus infection to receive daily multivitamins (including multiples of the recommended di

81 4 y at enrollment, with complete dietary and multivitamin information, 162 men and 104 women develope

82 nterventions with modifiable factors such as multivitamin intake may reduce risk.

83 iated with offspring BP after confounding by multivitamin intake was accounted for, and no associatio

84 ion with vitamin C, lutein, zeaxanthin, or a multivitamin may help certain populations, but is unlike

85 The intake of periconceptional multivitamins may decrease the risk of preterm births (P

86 neral deficiency, there is a perception that multivitamins may prevent cardiovascular disease (CVD).

87 ed dietary supplements, 31% of subjects used multivitamin mineral (MVM) products exclusively, 4% of s

88 The increasing use of multivitamin-mineral dietary supplements in younger to o

89 to better policy in the field of vitamin and multivitamin-mineral supplement use should occupy our at

90 Multivitamin/mineral products (MVMs) are the dietary sup

91 ers, counseling by experts in nutrition, and multivitamin/mineral supplement after ITx could be of be

92 Although multivitamin/mineral supplements are commonly used in th

93 porated supplements to their diets (10% used multivitamin/mineral supplements), despite the restricti

94 By day 180, 166 (8%) children in the multivitamin multimineral supplement group versus 169 (9

95 By day 180, 489 (24%) children in the multivitamin multimineral supplement group versus 509 (2

96 Neither enhanced supplementation with multivitamin multimineral supplement versus iron and fol

97 1901 (95%) of 1997 assigned multivitamin multimineral supplement, 1911 (96%) of 1986

98 plementation with iron and folate-containing multivitamin multimineral supplements versus iron and fo

99 Multivitamin-multimineral (MVM) supplements are widely u

100 ast month, and 35% reported regular use of a multivitamin-multimineral (MVMM) product.

101 Multivitamin-multimineral composition databases use labe

102 A multivitamin-multimineral supplement with a combination

103 Eligible trials investigated daily multivitamin-multimineral supplementation for >/=1 y.

104 Use of multivitamin-multimineral supplements is widespread and

105 Multivitamin-multimineral treatment had no effect on mor

106 Multivitamin-multimineral treatment has no effect on mor

107 Across all studies, no effect of multivitamin-multimineral treatment on all-cause mortali

108 We aimed to determine whether multivitamin-multimineral treatment, used for primary or

109 n of one or a combination of components in a multivitamin/multimineral may accelerate cancer progress

110 S adults use dietary supplements and 33% use multivitamin/multimineral supplements.

111 Although multivitamins, multiminerals, and similar terms (eg, mul

112 Thus, multivitamins-multiminerals refers to products with wide

113 omes included use of any supplements; use of multivitamins/multiminerals (MVMM; defined as a product

114 l porridge and a separate dose of an aqueous multivitamin (MV) supplement between meals (control grou

115 The minimum dosage of multivitamins necessary for optimal benefits is unknown.

116 3 HIV-infected adults enrolled in a trial of multivitamins (not including vitamin D) in Tanzania.

117 , there was no significant effect of a daily multivitamin on major cardiovascular events (11.0 and 10

118 The effect of a daily multivitamin on major cardiovascular events did not diff

119 There was no significant effect of a daily multivitamin on prostate cancer (multivitamin and placeb

120 al studies are needed to clarify the role of multivitamins on CVD.

121 enrolled in a trial examining the effect of multivitamins on HIV disease progression.

122 Use of multivitamins only or multiple supplements in addition t

123 h National Birth Cohort (1997-2003) reported multivitamin or folate-only supplement use during a 12-w

124 formation is summarized for periconceptional multivitamin or folic acid intake, which may reduce the

125 were observed for breast-feeding or maternal multivitamin or folic acid supplement use.

126 STF reviewed the evidence on the efficacy of multivitamin or mineral supplements in the general adult

127 Multivitamin or placebo daily.

128 Daily multivitamin or placebo.

129 ndazole twice daily for 3 d or 90 d of daily multivitamins or both using a 2 x 2 factorial design.

130 posure during the periconceptional period to multivitamins or liver consumption would decrease cleft

131 tene, vitamin C, vitamin D plus calcium, and multivitamins or multi-ingredient supplements was either

132 Most commonly used DSs were multivitamins or multiminerals (37.5%), protein and amin

133 roups were as follows: lt 150 microg/d (low; multivitamins or no supplement), 150-999 microg/d (middl

134 Weak support exists for multivitamins or other vitamin supplements from observat

135 ethylation was also seen with current use of multivitamins (OR, 0.57; 95% CI, 0.40-0.83).

136 E), preformed vitamin A and beta-carotene + multivitamins, or placebo.

137 higher than among women who did not receive multivitamins (P=0.07).

138 Women in the control group received multivitamin pills, and the intervention group received

139 cipants receiving the combined supplement of multivitamins plus selenium had a significantly lower ri

140 Multivitamins plus selenium in a single supplement, vs p

141 ins and vitamins C and E, selenium alone, or multivitamins plus selenium, compared with placebo.

142 Iron (7 mg/d as multivitamin preparation with ferrous sulfate) or placeb

143 reparation with ferrous sulfate) or placebo (multivitamin preparation without iron) was given from 1

144 nation of major, minor and trace elements in multivitamin preparations and dietary supplements and, b

145 Multivitamin preparations are the most common dietary su

146 was applied to their assay in 13 commercial multivitamin preparations, revealing mostly higher amoun

147 metry in the quality control of multimineral/multivitamin preparations.

148 ation for deficits that are not prevented by multivitamin preparations.

149 Multivitamin products could be better formulated to redu

150 method is applicable for stability testing, multivitamin products shelf-life determination as well a

151 Treatment with the high-dose multivitamin reduced homocysteine but did not reduce the

152 c enzymes and antioxidants (a combination of multivitamins, selenium, and methionine) can control sym

153 Multivitamins should be considered for all pregnant wome

154 oroid organ cultures were treated with AREDS multivitamin solution (MVS) or ZnCl(2).

155 ancer at randomization, enrolled in a common multivitamin study that began in 1997 with treatment and

156 he authors evaluated the association between multivitamin supplement use and breast cancer risk in a

157 e of cancer provided detailed information on multivitamin supplement use.

158 urham, NC) and examined risk modification by multivitamin supplement use.

159 e observed among study subjects who reported multivitamin supplement use.

160 istics and tested the effect modification of multivitamin supplement use.

161 rient adequacy from food only was higher for multivitamin supplement users (n = 21,056) than for nonu

162 orbidity from overall or major cancers among multivitamin supplement users.

163 Ps in DNMT3A were associated with risk among multivitamin supplement users: 3' untranslated region (U

164 ly stomach cancer, for participants taking a multivitamin supplement, but this was in a borderline-de

165 se (ALT) in patients receiving the high-dose multivitamin supplement.

166 Multivitamin supplementation (partial correlation r(p)=0

167 +MV group, daily zinc supplementation alone, multivitamin supplementation alone, and the combined Zn+

168 evere deficiencies are prevented by standard multivitamin supplementation and what parameters are inf

169 ntrolled trial of high-dose vs standard-dose multivitamin supplementation for 24 months in 3418 patie

170 ch provides further support for the value of multivitamin supplementation in HIV-infected adults.

171 e prevention trial of male physicians, daily multivitamin supplementation modestly but significantly

172 However, the influence of multivitamin supplementation on cancer recurrence and de

173 We examined the effect of multivitamin supplementation on hemoglobin concentration

174 Multivitamin supplementation provided during pregnancy a

175 Multivitamin supplementation reduced the incidence of lo

176 Compared with placebo, multivitamin supplementation resulted in a hemoglobin in

177 Short-term multivitamin supplementation should be considered in pat

178 Compared with standard-dose multivitamin supplementation, high-dose supplementation

179 ritional deficits occurred despite long-term multivitamin supplementation, including vitamins B1, B12

180 The results of most large-scale trials of multivitamin supplements (combinations of > or = 2 vitam

181 Multivitamin supplements at a single dose of the RDA may

182 men without chronic diseases reported use of multivitamin supplements at least weekly over the past y

183 We investigated the efficacy of multivitamin supplements at single compared with multipl

184 In adults receiving HAART, use of high-dose multivitamin supplements compared with standard-dose mul

185 Approximately 20-30% of Americans consume multivitamin supplements daily, indicating high public i

186 amin supplements compared with standard-dose multivitamin supplements did not result in a decrease in

187 omen received prenatal iron, folic acid, and multivitamin supplements irrespective of experimental as

188 Multivitamin supplements may place a subgroup of women (

189 a small, borderline-significant benefit from multivitamin supplements on cancer in men only and no ef

190 Multivitamin supplements represent a major source of mic

191 -year average daily dose from individual and multivitamin supplements were the exposures of primary i

192 To clarify the effects of multivitamin supplements, several large randomized clini

193 Despite widespread use of multivitamin supplements, their effect on cognitive heal

194 Only one-third of patients were taking multivitamin supplements.

195 m food and supplements; or vitamin C or E or multivitamin supplements.

196 e to assuming a default nutrient profile for multivitamin supplements.

197 e for the templates and can detect them from multivitamin tablets, corn flakes, energy drinks, cerebr

198 110 stable kidney transplant recipients to a multivitamin that included either a high dose (n=2056) o

199 eted villages, 951 (74.3%) of 1280 available multivitamin tickets were redeemed compared with 940 (66

200 The human Na(+)/multivitamin transporter (hSMVT) has been suggested to t

201 Na(+)-coupled I(-) uptake by the human Na(+)/multivitamin transporter (hSMVT), a related protein isol

202 53 HIV-negative pregnant women enrolled in a multivitamin trial at 12-27 weeks of gestation.

203 anzanian adults initiating ART enrolled in a multivitamin trial was followed at monthly clinic visits

204 uble-blind, placebo-controlled trial testing multivitamin use (multivitamin [Centrum Silver] or place

205 Multivitamin use (odds ratio (OR) = 1.46, 95% CI: 1.09,

206 Multivitamin use also did not improve the rates of grade

207 vitamin B(6), vitamin B(12), methionine) and multivitamin use among 497 Hodgkin lymphoma patients and

208 data indicate no overall association between multivitamin use and breast cancer risk but suggest that

209 e, no long-term clinical trials have studied multivitamin use and cognitive decline in older persons.

210 wn inconsistent associations between regular multivitamin use and CVD, with no long-term clinical tri

211 se association was observed between baseline multivitamin use and major CVD events among women aged >

212 founders, no associations were found between multivitamin use and mortality from all causes (for user

213 Multivitamin use and nutrient intakes were assessed with

214 as used to estimate the relation between any multivitamin use and PTBs (<37 wk) or SGA births (birth

215 The association between periconceptional multivitamin use and PTBs varied according to prepregnan

216 ermine the relation between periconceptional multivitamin use and the risk of small-for-gestational-a

217 tamin D intake on CVD mortality, and between multivitamin use and vitamin B12 intake on CVD mortality

218 nt interaction effects were observed between multivitamin use and vitamin B6 intake on myocardial inf

219 B6 intake on myocardial infarction, between multivitamin use and vitamin D intake on CVD mortality,

220 Diet and multivitamin use are unlikely to consistently prevent de

221 Multivitamin use attenuated the increased risk of breast

222 In multivariable analyses, multivitamin use compared with no use was not associated

223 Similarly, multivitamin use during adjuvant chemotherapy was not si

224 Among 1,038 patients, 518 (49.9%) reported multivitamin use during adjuvant chemotherapy.

225 Patients reported on multivitamin use during and 6 months after adjuvant chem

226 Multivitamin use during and after adjuvant chemotherapy

227 When updating information on multivitamin use during the course of follow-up, no asso

228 Current multivitamin use for > or =20 years or > or =6 times/wee

229 thers received antiretroviral (ARV) therapy, multivitamin use had no effect on mortality but was asso

230 Long-term multivitamin use had no effect on risk of cardiovascular

231 ii who answered an open-ended question about multivitamin use in 1999-2001 reported using 1246 differ

232 7-2001) reported at enrollment their regular multivitamin use in the past 6 months (n=1,823).

233 Regular preconception and postconception multivitamin use in women with a prepregnancy BMI (in kg

234 Recent epidemiologic findings suggest that multivitamin use increases the risk of mortality.

235 In this study, we evaluated whether diet and multivitamin use influenced the prevalence of gene promo

236 ovides the first epidemiologic evidence that multivitamin use is associated with longer telomere leng

237 The objective was to examine whether multivitamin use is associated with longer telomeres in

238 The objective was to investigate how multivitamin use is associated with the long- and short-

239 Multivitamin use is widespread in the United States, esp

240 The timing and frequency of periconceptional multivitamin use may be related to the risk of preeclamp

241 use and breast cancer risk but suggest that multivitamin use might reduce risk for women consuming a

242 ale physicians indicate that long-term daily multivitamin use modestly and significantly decreased th

243 dest suggestive inverse association (current multivitamin use of >/=6 times per week vs nonuse multiv

244 rsons who had a 10-year average frequency of multivitamin use of 6-7 days per week with nonusers was

245 line nutritional biomarkers on the effect of multivitamin use on CVD and other outcomes.

246 or baseline supplement use on the effect of multivitamin use on CVD end points.

247 influence the effect of randomized long-term multivitamin use on major CVD events.

248 There was no effect of multivitamin use on risk of preterm births (34-<37 weeks

249 Multivitamin use reported 6 months after completion of a

250 Greater frequency of multivitamin use showed a modest suggestive inverse asso

251 the timing and frequency of periconceptional multivitamin use to SGA births and PTBs and its clinical

252 Regular periconceptional multivitamin use was associated with a reduced risk of p

253 age, and household density, periconceptional multivitamin use was associated with a reduced risk of p

254 Daily multivitamin use was associated with a reduction in tota

255 her potential confounders were adjusted for, multivitamin use was associated with longer telomeres.

256 Regular periconceptional multivitamin use was associated with reduced risk of SGA

257 There also was no evidence indicating that multivitamin use was associated with risk of cancer, ove

258 rly women, neither baseline nor time-varying multivitamin use was associated with the long-term risk

259 Multivitamin use was nonsignificantly associated with a

260 Multivitamin use was nonsignificantly inversely associat

261 Multivitamin use was not associated with survival outcom

262 Multivitamin use was not related to total mortality.

263 Multivitamin use was not significantly associated with o

264 c acid, vitamin C, vitamin D, vitamin E, and multivitamin use were in the same range.

265 To assess the relation of multivitamin use with mortality and cancer, the authors

266 provided evidence regarding associations of multivitamin use with total and site-specific cancer inc

267 cal activity, vitamin D intake, fish intake, multivitamin use, and calcium supplement use.

268 smoking (never compared with ever smokers), multivitamin use, season of BMD measurement (for cross-s

269 nd CVD, with no long-term clinical trials of multivitamin use.

270 18,551 women (65%) reported periconceptional multivitamin use.

271 longer telomeres, even after adjustment for multivitamin use.

272 ion (P = 0.06) between the DHFR genotype and multivitamin use.

273 for maternal race/ethnicity, education, and multivitamin use.

274 ssociated with greater breast cancer risk in multivitamin users (51.2% of the study population) with

275 end = 0.05; P for interaction = 0.01] and in multivitamin users (OR for highest compared with the low

276 e DNA was on average 5.1% longer among daily multivitamin users (P for trend = 0.002).

277 adjusted risk of an SGA birth was reduced in multivitamin users regardless of their prepregnancy BMI

278 ith a body mass index of 22 kg/m(2), regular multivitamin users with the same body mass index had a 2

279 who reported a high intake of vitamin E, in multivitamin users, and in smokers.

280 For multivitamin users, the prevalence of adequacy improved

281 ncy and throughout the first 2 y postpartum: multivitamin, VA/BC, multivitamin including VA/BC, or pl

282 reviously reported that supplementation with multivitamins (vitamin B complex, vitamin C, and vitamin

283 he authors evaluated how supplemental use of multivitamins, vitamin C, and vitamin E over a 10-year p

284 We assessed the effect of daily zinc, multivitamin (vitamins C, E, and B-complex), and zinc an

285 to receive 3 mg/kg/day of elemental iron and multivitamins (vitamins A, C, and D) or multivitamins al

286 ts of preformed vitamin A and beta-carotene, multivitamins (vitamins B, C, and E), preformed vitamin

287 .0 and 10.8 events per 1000 person-years for multivitamin vs placebo, respectively; hazard ratio [HR]

288 A daily multivitamin was also not significantly associated with

289 individual supplement sources, but not from multivitamins, was associated with a 30% to 40% increase

290 In analyses restricted to nonusers of multivitamins, we observe a modest inverse trend between

291 obin concentrations among women who received multivitamins were 0.33 g/dL higher than among women who

292 Dietary data and habitual use of multivitamins were assessed from a modified Block food-f

293 er, coffee, beer, liquor, total alcohol, and multivitamins were each correlated with at least one met

294 Multivitamins were systematically prescribed after GBP,

295 Taking a multivitamin with minerals postbariatric surgery is a st

296 mized, placebo-controlled clinical trials of multivitamins with cancer as the primary endpoint have b

297 ns and vitamins C and E), selenium alone, or multivitamins with selenium vs placebo in a factorial de

298 supplements of vitamins C and E and low-dose multivitamins with the risk of age-related cataract amon

299 (vitamins C, E, and B-complex), and zinc and multivitamin (Zn+MV) supplementation on growth in infant

300 ants were randomly assigned to receive zinc, multivitamins, Zn+MVs, or a placebo at 6 wk of age and w